Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study-Reference-Cited by-同舟云学术

Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study

Published:2018-03-07 Issue:4 Volume:70 Page:592-599
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Ballegaard Christine¹,Højgaard Pil¹,Dreyer Lene²,Cordtz René¹,Jørgensen Tanja Schjødt³,Skougaard Marie³,Tarp Simon³,Kristensen Lars Erik³

Affiliation:

1. The Parker Institute and Copenhagen University Hospital; Bispebjerg and Frederiksberg Hospital; and Gentofte Hospital; Hellerup Denmark

2. The Parker Institute and Copenhagen University Hospital; Bispebjerg and Frederiksberg Hospital; and Gentofte Hospital, Hellerup; and DANBIO Registry and Rigshospitalet; Glostrup Denmark

3. The Parker Institute and Copenhagen University Hospital and Bispebjerg and Frederiksberg Hospital; Hellerup Denmark

Funder

Janssen-Cilag A/S

NordForsk

Oak Foundation

The Danish Psoriasis Association

Bispebjerg and Frederiksberg Hospital

Clara Hansens Mindelegat

Muskellaboratoriets Fond

Publisher

Wiley

Subject

Rheumatology

Reference42 articles.

1. Psoriatic arthritis: epidemiology, diagnosis, and treatment;Liu;World J Orthop,2014

2. Advances in the management of psoriatic arthritis;Olivieri;Nat Rev Rheumatol,2014

3. Managing comorbid disease in patients with psoriatic arthritis;Husni;Curr Rheumatol Rep,2010

4. Recognizing and managing comorbidities in psoriatic arthritis;Ogdie;Curr Opin Rheumatol,2015

5. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update;Gossec;Ann Rheum Dis,2016

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases;Arthritis Research & Therapy;2024-09-04

2. The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis;Expert Opinion on Biological Therapy;2024-07-26

3. Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: a single centre cohort study;Rheumatology International;2024-06-25

4. Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark—an observational registry study of 30 100 Danish patients with glaucoma;BMJ Open Ophthalmology;2024-04

5. Patients With Psoriatic Arthritis–Related Enthesitis and Persistence on Tofacitinib Under Real-World Conditions;The Journal of Rheumatology;2024-04-01